Lack of prognostic value of EGFR mutations in primary resected non-small cell lung cancer

Author： Lim Ken-Hong Huang Ming-Jer Liu Hung-Chang Kuo Hsu-Tah Tzen Chin-Yuan Hsieh Ruey-Kuen

ISSN： 1357-0560

Source： Medical Oncology, Vol.24, Iss.4, 2007-12, pp. : 388-393

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Impact of EGFR mutations on treatment of non-small cell lung cancer

By Johnson Bruce Jackman David Jänne Pasi

Cancer Chemotherapy and Pharmacology, Vol. 58, Iss. 7, 2006-11 ,pp. : 5-9

Springer Publishing Company

Access to resources Recommend Favorite

Impact of EGFR mutations on treatment of non-small cell lung cancer

By Johnson Bruce Jackman David Jänne Pasi

Cancer Chemotherapy and Pharmacology, Vol. 58, Iss. 1, 2006-11 ,pp. : 5-9

Springer Publishing Company

Access to resources Recommend Favorite

Heterogeneity of the EGFR mutation status between the primary tumor and metastatic lymph node and the sensitivity to EGFR tyrosine kinase inhibitor in non-small cell lung cancer

By Shimizu Katsuhiko Yukawa Takuro Hirami Yuji Okita Riki Saisho Shinsuke Maeda Ai Yasuda Koichiro Nakata Masao

Targeted Oncology, Vol. 8, Iss. 4, 2013-12 ,pp. : 237-242

Springer Publishing Company

Access to resources Recommend Favorite

The impact and role of EGFR gene mutation on non-small cell lung cancer

By Toyooka Shinichi Soh Junichi Shigematsu Hisayuki Aoe Motoi Date Hiroshi

Cancer Chemotherapy and Pharmacology, Vol. 58, Iss. 7, 2006-11 ,pp. : 25-31

Springer Publishing Company

Access to resources Recommend Favorite

The impact and role of EGFR gene mutation on non-small cell lung cancer

By Toyooka Shinichi Soh Junichi Shigematsu Hisayuki Aoe Motoi Date Hiroshi

Cancer Chemotherapy and Pharmacology, Vol. 58, Iss. 1, 2006-11 ,pp. : 25-31

Springer Publishing Company

Access to resources Recommend Favorite